CD44 and pancreatic ductal adenocarcinoma: Furthermore, the separation of pancreatic ductal adenocarcinoma (PDAC) cell lines with different CD44 level uncovered a correlation between high CD44 level and enhanced CSC-like properties, including elevated tumorigenicity, clonogenic abilities, and therapy resistance in vivo (Zhao et al., 2016).